These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions. Cao J, Xiao L, He B, Zhang G, Dong J, Wu Y, Xie H, Wang G, Lin X. Clin Radiol; 2017 Sep; 72(9):793.e1-793.e9. PubMed ID: 28545685 [Abstract] [Full Text] [Related]
7. Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome. Anzidei M, Napoli A, Sacconi B, Boni F, Noce V, Di Martino M, Saba L, Catalano C. Radiol Med; 2016 Dec; 121(12):905-915. PubMed ID: 27567615 [Abstract] [Full Text] [Related]
8. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T. Dong Y, Liu Q. J Comput Assist Tomogr; 2012 Dec; 36(4):361-6. PubMed ID: 22805661 [Abstract] [Full Text] [Related]
14. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T. Del Grande F, Subhawong T, Weber K, Aro M, Mugera C, Fayad LM. Radiology; 2014 May; 271(2):499-511. PubMed ID: 24495264 [Abstract] [Full Text] [Related]
15. Value added: functional MR imaging in management of bone and soft tissue sarcomas. Subhawong TK, Wilky BA. Curr Opin Oncol; 2015 Jul; 27(4):323-31. PubMed ID: 26049272 [Abstract] [Full Text] [Related]
16. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors. Aribal E, Asadov R, Ramazan A, Ugurlu MÜ, Kaya H. Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059 [Abstract] [Full Text] [Related]
17. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China. Fan WX, Chen XF, Cheng FY, Cheng YB, Xu T, Zhu WB, Zhu XL, Li GJ, Li S. Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183 [Abstract] [Full Text] [Related]
18. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions. Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ. J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383 [Abstract] [Full Text] [Related]